What Is It Like to Die of Liver Failure?

Discover the progressive physical and cognitive impact of terminal liver failure and how comfort care supports the end-of-life journey.

Dying of liver failure is not a single event but a prolonged, uneven decline in which the body loses its ability to perform hundreds of chemical tasks at once. The experience varies depending on whether the failure is sudden or the end stage of chronic cirrhosis, but it typically involves mounting physical exhaustion, fluid accumulation that makes breathing and movement difficult, episodes of confusion that can deepen into unconsciousness, and a susceptibility to dangerous complications like internal bleeding and infection. For many people and their families, the hardest part is the unpredictability: stretches of relative stability interrupted by crises that each leave the person a little worse off than before.

The Overwhelming Fatigue

The symptom that dominates end-stage liver disease more than any other is exhaustion. In a prospective study of patients with end-stage liver disease, asthenia (a clinical term for deep, unrelenting fatigue) was reported by more than three-quarters of patients, and every single person who reported it rated the intensity as moderate to high. This is not ordinary tiredness. It is a bone-deep depletion that does not improve much with rest, driven by the liver’s failing ability to process nutrients, manufacture proteins, and clear toxins from the blood.

A major contributor is the progressive loss of muscle mass. Sarcopenia is extremely common in cirrhosis and results from a cascade of problems: the body struggles to build new muscle protein while simultaneously breaking existing muscle down faster than normal. Elevated ammonia in the blood, chronic inflammation, poor nutrient absorption, and physical inactivity all feed into this cycle. The result is frailty: a state where the body has so little reserve that even small stressors like a mild infection or a fall can trigger a serious decline. People who were once active find themselves unable to walk across a room without resting.

Fluid, Swelling, and the Struggle to Breathe

One of the most visible and distressing features of advanced liver disease is ascites, the accumulation of fluid in the abdomen. As the liver scars and stiffens, blood pressure in the portal vein rises, and the body begins leaking fluid into the abdominal cavity. In mild cases, this causes bloating and discomfort. In severe cases, the belly becomes enormously distended, pressing upward on the diaphragm and making it genuinely hard to breathe. Patients with refractory ascites, the kind that no longer responds to diuretics or salt restriction, experience severe abdominal distension, pain, and shortness of breath, and face a grim prognosis: roughly a one-in-two to one-in-four chance of surviving a year.

Draining the fluid through a procedure called paracentesis provides temporary relief, but the fluid comes back, sometimes within days. The repeated cycle of filling and draining is exhausting and demoralizing. And the fluid does not just collect in the abdomen. Legs and feet swell. Fluid can accumulate around the lungs. Every movement becomes heavier and more effortful.

The Relentless Itch

People outside the liver disease world rarely appreciate how tormenting the itching can be. Cholestatic pruritus, caused by the buildup of bile compounds the liver can no longer clear, is generalized, chronic, and can range from mildly annoying to absolutely unbearable. One distinctive feature is that it often starts and is worst on the palms of the hands and soles of the feet, a pattern not seen in most other skin conditions.

About two-thirds of patients with primary biliary cholangitis report that the itching is worst at night, which means it devastates sleep. Sleep deprivation compounds the fatigue, worsens confusion, and erodes emotional resilience. In extreme cases, the itch has been linked to depression and suicidal thoughts. Treatments exist, including bile acid binders and opioid receptor blockers, but they do not work for everyone, and the itch does not reliably correlate with how severe the liver disease is on paper. Some patients with terrible numbers on blood tests feel fine; others with relatively modest lab results are clawing at their skin.

When the Mind Starts to Go

Perhaps the most frightening aspect of liver failure, for both the person experiencing it and those around them, is hepatic encephalopathy. When the liver cannot filter ammonia and other toxins from the blood, those substances reach the brain. The effects range across a wide spectrum of mental and motor disturbances, from subtle difficulty concentrating all the way to coma and death.

In early stages, the changes are easy to miss or misinterpret. A person might reverse their sleep-wake cycle, sleeping during the day and lying awake at night. They might become uncharacteristically irritable, or make small errors in judgment that family members notice but doctors might not catch in a brief visit. As it progresses, personality changes become more pronounced. Speech slows. Hands develop a distinctive flapping tremor. The person may become disoriented, not knowing where they are or what day it is.

In the later stages, the person becomes increasingly difficult to rouse and eventually unresponsive. The interaction between ammonia and systemic inflammation appears to accelerate this deterioration: infection or internal bleeding can push someone from mild confusion into deep stupor within hours. An important thing for families to know is that hepatic encephalopathy is, at least in principle, reversible if the underlying trigger is treated. Someone who appears to be in a coma one day can sometimes wake up and have a coherent conversation after treatment. But with each episode, recovery tends to be less complete, and the baseline cognitive function drifts downward. The unpredictable oscillation between clarity and confusion is one of the most emotionally wrenching features of the disease for caregivers.

Complications That Can Kill Quickly

Liver failure does not usually end with a gentle fading. It tends to involve one or more catastrophic complications, any of which can be fatal on its own.

In acute liver failure, these organ failures pile up fast. A study comparing acute liver failure to acute-on-chronic liver failure found that about six in ten patients with acute failure developed multi-organ dysfunction. When the liver, kidneys, brain, and lungs are all failing simultaneously, the experience is one of escalating medical intervention: intubation, dialysis, vasopressors, and intensive monitoring, with the person frequently sedated or unconscious during the final days.

The Pain Paradox

Pain is common in end-stage liver disease, reported by more than four in ten patients in one prospective study, with the large majority rating it as moderate to severe. Sources of pain include the stretched abdominal wall from ascites, muscle cramps from electrolyte imbalances, and general body aches from malnutrition and wasting. Yet treating that pain is extraordinarily difficult. Common anti-inflammatory drugs can trigger kidney failure in someone whose kidneys are already on the edge. Opioids, metabolized by the liver, accumulate unpredictably and can precipitate hepatic encephalopathy or dangerous sedation.

This means doctors are often forced to under-treat pain to avoid making everything else worse. Patients end up caught between inadequate pain relief and the risk of complications from the medications themselves. Families watching this unfold feel helpless, and it is one of the most common sources of conflict between caregivers and medical teams.

The Bleeding Body

The liver manufactures most of the proteins the blood needs to clot. As liver function deteriorates, clotting becomes unreliable. At the same time, the liver also produces natural anticoagulants, which are declining too, so the system enters a state of unstable equilibrium: sometimes bleeding too easily, sometimes forming dangerous clots. Platelet counts drop because the enlarged spleen traps and destroys them. Clotting factors become insufficient.

In practical terms, this means that bruising happens easily. Gums bleed. Nosebleeds are frequent. Small procedures like drawing blood or placing an IV become riskier. The visible bruising and bleeding are distressing in themselves, but the real danger is internal: a ruptured varix, a bleeding ulcer, or hemorrhage during any surgical intervention. Every medical decision must be weighed against the risk that the person will not stop bleeding.

Losing the Ability to Eat

Appetite loss is reported by more than four in ten end-stage liver disease patients, making it one of the top three symptoms alongside fatigue and pain. Part of the explanation appears to be that liver disease physically changes how food tastes. Taste disturbances become dramatically more common as liver function declines: one study found that only about five percent of patients without liver fibrosis had impaired taste, compared to roughly a third of those with advanced fibrosis, and nearly six in ten of those with decompensated liver disease. Among decompensated patients with taste disturbances, about nine in ten also reported appetite loss, and none had appetite loss without also having altered taste. Food becomes unappetizing or tastes metallic or strange, which feeds a vicious cycle: the person eats less, loses more muscle, becomes weaker, and the liver disease itself accelerates from the malnutrition.

This is a source of enormous frustration for families, who understandably want to help by preparing food. Watching someone waste away while being unable to get them to eat is one of the most painful aspects of caregiving in this disease.

What Families Go Through

The experience of liver failure extends far beyond the patient. Qualitative interviews with patients and bereaved caregivers describe a trajectory of escalating physical, psychological, and social needs, including disabling symptoms, emotional distress, uncertainty about the future, financial hardship, and social isolation. Hepatic encephalopathy creates a particularly heavy burden on families: the person they love may not recognize them, may become agitated or aggressive, may say things that are hurtful without any awareness of it. Caregivers describe a grief that begins long before death, mourning the personality changes and the loss of the relationship as they knew it.

Research consistently finds that caregivers and patients feel unprepared when transitioning from hospital to home after a diagnosis of end-stage liver disease. The delay in getting supportive services leads to hospital readmissions, emotional distress, caregiver burnout, reduced work capacity, and financial pressure. Unlike cancer, where palliative care pathways are relatively well-established, liver disease has historically been treated as a condition to be cured (via transplant) or not at all, leaving patients and families in a gap where supportive care is underdeveloped.

Delirium Near the End

As death approaches, many patients with liver failure experience delirium, a state of fluctuating consciousness and confusion that goes beyond hepatic encephalopathy. The hypoactive form, where the person becomes quiet, withdrawn, and difficult to arouse rather than agitated, is the most commonly missed by clinicians. Family members sometimes misread this as peaceful sleep when the person is actually in significant distress. Poorly managed delirium increases distress for both the patient and those around them.

In the final hours to days, consciousness generally fades. The person may not respond to voices or touch. Breathing becomes irregular. Jaundice deepens, giving the skin and eyes a dark yellow or even greenish tinge. The smell of the breath may change, a sweetish, musty odor sometimes called fetor hepaticus, caused by sulfur compounds the liver can no longer metabolize. For families keeping vigil, these sensory details, the color changes, the smell, the labored breathing, become indelible memories.

What Patients Awaiting Transplant Experience

For those on transplant waiting lists, the experience of liver failure carries an additional psychological weight: the constant awareness that rescue is theoretically possible but far from guaranteed. Studies of transplant candidates find significantly reduced quality of life and elevated depression compared to both healthy people and patients with liver disease who have not progressed to the transplant stage. The wait involves enduring all the symptoms described above while knowing that a phone call could change everything, or might never come. Each new complication raises the question of whether it disqualifies you from receiving a transplant, or whether it pushes you higher on the list. The emotional whiplash between hope and despair is a defining feature of this liminal period.

Patients who are not transplant candidates face a different psychological landscape: the certainty that the trajectory only goes one direction. For these individuals, early involvement of palliative care teams has been shown to address symptom burden more aggressively, with higher rates of pain and fatigue being identified and treated when palliative specialists are involved. Yet access to palliative care and hospice services remains inconsistent for liver disease patients, who are often caught in a medical system that was built around the binary of transplant or nothing.